Literature DB >> 26228687

Hepatitis C virus infection in Taiwan: Past, present, and future.

Jia-Horng Kao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26228687     DOI： 10.1016/j.jfma.2015.06.012

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN： 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  12 in total

1.  Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.

Authors:  Wei-Liang Liu; Hung-Chih Yang; Ching-Sheng Hsu; Chih-Chiang Wang; Tzu-San Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-06       Impact factor: 11.205

2.  High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.

Authors:  Hsiao-Ching Nien; Shih-Jer Hsu; Tung-Hung Su; Po-Jen Yang; Jin-Chuan Sheu; Jin-Town Wang; Lu-Ping Chow; Chi-Ling Chen; Jia-Horng Kao; Wei-Shiung Yang
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

3.  Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan.

Authors:  Yu-Chung Tsao; Jau-Yuan Chen; Wei-Chung Yeh; Yun-Shing Peng; Wen-Cheng Li
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

4.  Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

Authors:  Mei-Hsuan Lee; Chung-Feng Huang; Hsueh-Chou Lai; Chun-Yen Lin; Chia-Yen Dai; Chun-Jen Liu; Jing-Houng Wang; Jee-Fu Huang; Wen-Pang Su; Hung-Chih Yang; Kwong-Ming Kee; Ming-Lun Yeh; Po-Heng Chuang; Shih-Jer Hsu; Ching-I Huang; Jung-Ta Kao; Chieh-Chang Chen; Sheng-Hung Chen; Wen-Juei Jeng; Hwai-I Yang; Yong Yuan; Sheng-Nan Lu; I-Shyan Sheen; Chen-Hua Liu; Cheng-Yuan Peng; Jia-Horng Kao; Ming-Lung Yu; Wan-Long Chuang; Chien-Jen Chen
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

5.  Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.

Authors:  Chen-Hua Liu; Chun-Jen Liu; Tung-Hung Su; Yu-Jen Fang; Hung-Chih Yang; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Open Forum Infect Dis       Date:  2017-02-11       Impact factor: 3.835

6.  Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.

Authors:  Chen-Hua Liu; Chun-Jen Liu; Tung-Hung Su; Hung-Chih Yang; Chun-Ming Hong; Tai-Chung Tseng; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

7.  Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study.

Authors:  Yeo Wool Kang; Yang Hyun Baek; Sung Wook Lee; Sung Jae Park; Jun Sik Yoon; Ki Tae Yoon; Youngmi Hong; Nae Yun Heo; Kwang Il Seo; Sang Soo Lee; Hyun Chin Cho; Jung Woo Shin
Journal:  J Korean Med Sci       Date:  2021-05-31       Impact factor: 2.153

8.  Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.

Authors:  Chen-Hua Liu; Wang-Hui Sheng; Hsin-Yun Sun; Szu-Min Hsieh; Yi-Chun Lo; Chun-Jen Liu; Tung-Hung Su; Hung-Chih Yang; Wen-Chun Liu; Pei-Jer Chen; Ding-Shinn Chen; Chien-Ching Hung; Jia-Horng Kao
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

9.  Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.

Authors:  Ching-Sheng Hsu; Shih-Jer Hsu; Wei-Liang Liu; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

10.  Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.

Authors:  Chen-Hua Liu; Yi-Jie Huang; Sien-Sing Yang; Chung-Hsin Chang; Sheng-Shun Yang; Hsin-Yun Sun; Chun-Jen Liu; Wen-Chun Liu; Tung-Hung Su; Hung-Chih Yang; Chun-Ming Hong; Tai-Chung Tseng; Pei-Jer Chen; Ding-Shinn Chen; Chien-Ching Hung; Jia-Horng Kao
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.